title: [German adrenocortical carcinoma registry. Surgical therapy results and follow-up treatment].
abstract: Adrenocortical carcinoma (ACC) is a highly aggressive endocrine disease with an incidence of 1-2 cases per million population per year. Due to the low incidence of ACC knowledge concerning the surgical management is mainly based on retrospective studies or recommendations of isolated experts. Cancer databases, such as the German ACC registry are prerequisite to collect and evaluate clinical data from a large number of patients. For non-metastatic tumor stages, complete tumor resection is the only treatment with curative intent. Open surgery remains the recommended approach for ACC. However, in small tumors with uncertain malignancy a laparoscopic resection by an expert surgeon can be considered. A loco-regional lymphadenectomy should be part of the primary surgical treatment of ACC. Tumor recurrence is common even after an apparently complete primary resection. Therefore, based on the individual risk (tumor size, resection status, proliferation index) adjuvant mitotane treatment is recommended in most patients. Patients with low-risk should be included in the ADIUVO trial. In case of tumor relapse indications for a reoperation should be strongly considered, especially when the time interval since the primary surgery is long (> 12 months) and a complete resection of the recurrent disease seems to be feasible.
authors.affiliation: Klinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie, Universitätsklinikum Würzburg, Würzburg, Deutschland.
authors.forename: J
authors.initials: J
authors.lastname: Reibetanz
authors.forename: M
authors.initials: M
authors.lastname: Kroiss
authors.forename: T
authors.initials: T
authors.lastname: Deutschbein
authors.forename: W
authors.initials: W
authors.lastname: Fenske
authors.forename: M
authors.initials: M
authors.lastname: Gasser
authors.forename: C
authors.initials: C
authors.lastname: Jurowich
authors.forename: C-T
authors.initials: CT
authors.lastname: Germer
authors.forename: B
authors.initials: B
authors.lastname: Allolio
authors.forename: M
authors.initials: M
authors.lastname: Fassnacht
mesh_terms: D000306:Adrenal Cortex Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000473:pathology / Q000601:surgery*; D000315:Adrenalectomy / Q000379:methods*; D000359:Aftercare / Q000379:methods; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D006801:Humans; D010535:Laparoscopy / Q000379:methods; D008197:Lymph Node Excision / Q000379:methods; D059146:Metastasectomy / Q000379:methods; D008939:Mitotane / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control / Q000601:surgery; D009367:Neoplasm Staging; D012042:Registries; D012086:Reoperation
chemical_list: D018931:Antineoplastic Agents, Hormonal; D008939:Mitotane